Cargando…
Non-alcoholic fatty liver disease and lipotoxicity
Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but...
Autores principales: | Wasilewska, Natalia, Lebensztejn, Dariusz Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122097/ https://www.ncbi.nlm.nih.gov/pubmed/34027109 http://dx.doi.org/10.5114/ceh.2021.104441 |
Ejemplares similares
-
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
por: Flisiak-Jackiewicz, Marta, et al.
Publicado: (2021) -
Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children
por: Flisiak-Jackiewicz, Marta, et al.
Publicado: (2019) -
Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018) -
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
por: Geng, Yana, et al.
Publicado: (2021) -
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
por: Wasilewska, Natalia, et al.
Publicado: (2018)